Bank of America Issues Dire Warning to ALL Customers - Take Action NOW!

Steven Van Metre
20 Oct 202422:09

Summary

TLDRThe video outlines a groundbreaking dual gene therapy program utilizing small interfering RNA (siRNA) to combat Type 2 diabetes and obesity. It targets key tissues—liver, skeletal muscle, and adipose tissue—aiming not only to manage but potentially cure these conditions. With diabetes-related healthcare costs projected to reach $82 billion by 2024, the program promises significant economic impact. The presenter also discusses swing trading strategies, highlighting a stock's potential for substantial gains based on historical price movements. Viewers are encouraged to conduct their own research before trading.

Takeaways

  • 😀 A new bioresponsive carrier system is being developed to target tissues involved in diabetes and obesity.
  • 📈 The program aims for preclinical evaluation to address genes implicated in type 2 diabetes and obesity.
  • 💰 The global cost of diabetes was estimated at $673 billion in 2015, with significant financial growth projected.
  • 🧬 The dual gene therapy program utilizes siRNA technology to silence genes responsible for fat storage and glucose regulation.
  • 🚀 Gene silencing could potentially cure diabetes instead of just managing it, especially for pre-diabetic patients.
  • 📊 Swing trading strategies focus on stocks closing above the 9-day moving average, indicating potential price increases.
  • 🔍 Historical stock patterns show that closing above the moving average often leads to a price rise.
  • 📉 Current trading levels for the featured stock are around 1.3 cents, with breakout potential at 1.7 cents.
  • 💼 The featured company, Practical Medical, is traded under the symbol CSSE and on OTCQX as PRVCF.
  • 📝 Viewers are encouraged to conduct their own research before making any investment decisions.

Q & A

  • What is the primary focus of the proprietary RNA technology discussed in the video?

    -The primary focus is on developing a bioresponsive carrier system that utilizes RNA technology for dual gene therapy targeting diabetes and obesity.

  • How does the gene silencing technology work in treating diabetes and obesity?

    -Gene silencing technology effectively turns off the genetic signals that lead to the overproduction of key protein molecules, thereby normalizing their levels to enhance glucose absorption and reduce fat storage.

  • What are the key tissues targeted by the dual gene therapy?

    -The dual gene therapy targets three prominent tissues implicated in diabetes and obesity: the liver, skeletal muscle, and adipose tissue.

  • What potential benefits does the gene therapy offer for pre-diabetic patients?

    -For pre-diabetic patients, the therapy can act as a preventive measure to halt the progression to full-blown diabetes, potentially curing or managing their condition more effectively.

  • What financial implications are associated with the increase in diabetes cases?

    -The global health costs related to diabetes are projected to increase significantly, with estimates of $673 billion in 2015 and $82 billion in the U.S. by 2024, indicating a substantial market opportunity for diabetes management solutions.

  • How does the speaker relate stock trading strategies to the biotechnology sector?

    -The speaker discusses swing trading strategies, particularly how to identify buying opportunities when a stock closes above the 9-day moving average, suggesting this could indicate a potential increase in stock value.

  • What is the significance of the 9-day moving average in stock trading?

    -The 9-day moving average serves as a trend indicator; when a stock consistently closes above it, it typically signals bullish momentum and the potential for the stock price to rise.

  • What does the speaker suggest about conducting research before investing?

    -The speaker emphasizes the importance of conducting thorough personal research before making any investment decisions, highlighting that viewers are under no obligation to purchase stocks featured in the discussion.

  • What is the projected upside potential for the stock mentioned in the video?

    -The speaker suggests that the stock could see an upside potential of as much as 100% if it breaks above key resistance levels.

  • What is the importance of monitoring volume profiles in stock trading?

    -Monitoring volume profiles helps traders identify potential breakout levels; increased volume at specific price points can indicate stronger buying interest and support for the stock.

Outlines

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Mindmap

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Keywords

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Highlights

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant

Transcripts

plate

Cette section est réservée aux utilisateurs payants. Améliorez votre compte pour accéder à cette section.

Améliorer maintenant
Rate This

5.0 / 5 (0 votes)

Étiquettes Connexes
Gene TherapyDiabetes TreatmentObesity CureHealth InnovationInvestment OpportunityRNA TargetingPrevention StrategyMarket InsightsClinical ResearchHealth Economics
Besoin d'un résumé en anglais ?